Sanofi (SNY) Interest & Investment Income (2017 - 2026)

Sanofi has reported Interest & Investment Income for 4 years, with the latest figure at -$28.1 million in Q1 2026.

• Quarterly Interest & Investment Income fell 634.24% year-over-year to -$28.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $205.4 million (changed N/A YoY) and the FY2025 annual result came in at $458.6 million, down 17.3% from the prior year.
• Interest & Investment Income eased to -$28.1 million in Q1 2026 per SNY's latest filing, from $25.6 million in the prior quarter.
• Over five years, Interest & Investment Income peaked at $202.6 million in Q2 2025 and troughed at -$109.0 million in Q4 2024.
• A 3-year average of $19.3 million and a median of $5.3 million in 2025 frame the typical range for Interest & Investment Income.
• The sharpest annual moves came in 2025 and 2026: Interest & Investment Income jumped 123.5% in 2025, then slumped 634.24% in 2026.
• Over 3 years, Interest & Investment Income stood at -$109.0 million in 2024, then surged by 123.5% to $25.6 million in 2025, then plunged by 209.72% to -$28.1 million in 2026.
• According to Business Quant data, Interest & Investment Income over the past three periods registered -$28.1 million, $25.6 million, and $202.6 million for Q1 2026, Q4 2025, and Q2 2025 respectively.